Quantitation of natural killer cell precursors in man

Journal of Immunological Methods

Volumn 260, Issue 1-2, 2002, Pages 69-77

  Gharehbaghian, Ahmad ^a,b   Gausul Haque, K M ^a   Truman, Carol ^a   Newman, John ^c   Bradley, Benjamin A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b Iranian Nat Blood Transf Serv   (Iran)

^c SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

Europium release; Limiting dilution analysis; Natural killer cell precursor frequency; rIL 15; rIL 2

Indexed keywords

EUROPIUM; RECOMBINANT INTERLEUKIN 15; RECOMBINANT INTERLEUKIN 2;

ADULT; AGED; ALLOGRAFT; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL COUNT; CELL CULTURE; CELL FUNCTION; CELL LABELING; CELL MATURATION; CELL STRAIN K 562; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOFLUOROMETRY; DILUTION; HUMAN; HUMAN CELL; INCUBATION TIME; INTERMETHOD COMPARISON; IRRADIATION; MALE; MONONUCLEAR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; QUANTITATIVE ASSAY; STEM CELL; SUPERNATANT; TARGET CELL; TECHNIQUE; VENOUS BLOOD;

AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; CELL SEPARATION; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; K562 CELLS; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; STEM CELLS;

EID: 0036470322     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(01)00534-8     Document Type: Article

References (43)

1. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
2. Interleukin-15 mRNA is expressed by human keratinocytes Langerhans cells, and blood-derived dendritic cells and is downregulated by ultraviolet B radiation
3. Europium-labelled target cells in an assay of natural killer cell activity. I. A novel non-radioactive method based on time-resolved fluorescence
4. Europium-labelled target cells in an assay of natural killer cell activity: II. A novel non-radioactive method based on time-resolved fluorescence, significance and specificity of the method
5. NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions
6. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor
7. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro
8. A potential role for interleukin-15 in the regulation of human natural killer cell survival
9. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain
10. IL-2R alpha on one cell can present IL-2 to IL-2R beta/gamma(c) on another cell to augment IL-2 signaling
11. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells
12. NKT cells: Facts, functions and fallacies
13. Interleukin-15 as an activator of natural killer cell-mediated antiviral response
14. Frequencies of cytotoxic T lymphocyte precursor estimate in three different populations
15. Natural killer (NK) cells
16. IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-gamma
17. Induction of IL-15 messenger RNA and protein in human blood-derived dendritic cells: A role for IL-15 in attraction of T cells
18. Regulation of adaptive immunity by natural killer cells
19. The emerging role of IL-15 in NK-cell development
20. Enhancement of natural killer and antibody-dependent cytolytic activities of the peripheral blood mononuclear cells of HIV-infected patients by recombinant IL-15
21. Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12
22. Single adult human CD34(+)/Lin-/CD38(-) progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells
23. Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells
24. Application of non-radioactive europium (Eu3+) release assay to a measurement of human natural killer activity of healthy and patient populations
25. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells
26. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans
27. Elimination of established liver metastases by human interleukin 2-activated natural killer cells after locoregional or systemic adoptive transfer
28. Induction by interleukin-7 of lymphokine-activated killer activity in lymphocytes from autologous and syngeneic marrow transplant recipients before and after systemic interleukin-2 therapy
29. Differentiation of human NK cells into NK1 and NK2 subsets
30. Role of natural killer cells in cancer
31. The myeloid-lymphoid initiating cell (ML-IC) assay assesses the fate of multipotent human progenitors in vitro
32. Development and tolerance of natural killer cells
33. NK cell colony formation from human fetal thymocytes
34. Stimulation of natural killer activity in peripheral blood lymphocytes of healthy donors and melanoma patients in vitro: Synergism between interleukin (IL)-12 and IL-15 or IL-12 and IL-2
35. Development of self-recognition systems in natural killer cells
36. Limiting dilution assays. Experimental design and statistical analysis
37. Computer aided design and evaluation of limiting and serial dilution experiments
38. Adoptive immunotherapy of patients with metastatic renal cell cancer using lymphokine-activated killer cells, interleukin-2 and cyclophosphamide: Long-term results
39. Characterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: Association of the p64 IL-2R gamma chain with the IL-2R beta chain in functional intermediate-affinity IL-2R
40. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens
41. Interleukin-2, interleukin-15, and their receptors
42. Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12
43. Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15